@inproceedings{inproceedings, title  = {{A cost utility analysis of peginterferon alfa-2a (40KD) versus peginterferon alfa-2b (12KD) for the treatment of chronic hepatitis C (CHC) in the UK}},

 url = {{}},

 year = {{2005}},

 month = {{11}},

 author = {{Latimer NR and Lewis GJ}},

 volume = {{8}},

 journal = {{VALUE HEALTH}},

 issue = {{6}},

 pages = {{A58-A58}},

 note = {{Accessed on 2024/12/22}}}